Companies /Healthcare

Alignment Healthcare Inc

NASDAQ: ALHC Healthcare Plans
$8.70
▼ $0.01 (−0.11%) today
Markets closed · 12:53am ET

Q1 2025 Earnings

Reported May 1, 2025, 4:01pm ET · SEC source
$-0.05
Beat +30.56%
EPS · est. $-0.07
$926.9M
Beat +4.35%
Revenue · est. $888.3M
−6.5%
Trailing market
ALHC vs S&P since report
2 quarters
Consecutive EPS misses

Market Reaction

% change · around the report
−12%−6%0May 1May 2report 4:01pm ETearnings+1.9%−7.4%
−12%−6%0May 1May 2earnings+1.9%−7.4%
ALHC −7.4%S&P 500 +1.9%
−12%−6%0May 1May 2report 4:01pm ETearnings+2.2%−7.4%
−12%−6%0May 1May 2earnings+2.2%−7.4%
ALHC −7.4%NASDAQ +2.2%
−12%−6%0Apr 30May 9report 4:01pm ETearnings+1.4%−14.1%
−12%−6%0Apr 30May 9earnings+1.4%−14.1%
ALHC −14.1%S&P 500 +1.4%
−12%−6%0Apr 30May 9report 4:01pm ETearnings+1.9%−14.1%
−12%−6%0Apr 30May 9earnings+1.9%−14.1%
ALHC −14.1%NASDAQ +1.9%
−7.39%
Day of report
−0.32%
Next session
−2.64%
One week
−1.35%
30 days

S&P 500 over the same 30 days: +5.15%.

Did ALHC Beat Earnings? Q1 2025 Results

Alignment Healthcare opened 2025 with a standout quarter, posting a loss of $0.05 per share against a consensus estimate of $0.07, a 30.56% beat, while revenue of $926.93 million cleared Wall Street expectations by 4.35% and surged 47.5% year over year. The primary engine behind those figures was a 31.7% jump in Medicare Advantage membership to roughly 217,500 enrollees, a scale-driven expansion that pushed total revenue well above guidance and helped swing adjusted EBITDA to a positive $20.18 million from a loss of $11.98 million a year ago, marking a meaningful inflection toward sustainable profitability. The company also announced a CFO transition, with healthcare finance veteran Jim Head assuming the role on May 2, as outgoing CFO Thomas Freeman moves to a strategic advisory position. Looking ahead, management raised the midpoint of its full-year 2025 outlook, now targeting revenue of $3.77 billion to $3.82 billion and adjusted EBITDA of $38 million to $60 million, signaling confidence that its technology-integrated care model can sustain the momentum through year-end.

Key Takeaways
  • Medicare Advantage membership growth of 31.7% year over year to approximately 217,500 members
  • Revenue growth of 47.5% year over year driven by membership expansion
  • Medical benefits ratio of 88.4% based on adjusted gross profit
  • Adjusted EBITDA swung to $20.2 million profit from $(12.0) million loss year over year
  • Strong first-quarter clinical performance and enrollment growth momentum
  • Integration of technology, clinical management, and member-first service

“Alignment Healthcare's first-quarter performance reflects the strength of our model and the discipline of our execution, showing what's possible when technology, clinical management and member-first service operate as one. By staying focused on quality, clinical outcomes and member experience, we exceeded expectations across all key measures. With a strong start to the year and momentum building, we're confident in our ability to scale with purpose and deliver on our mission of Medicare Advantage done right.”

Alignment Healthcare CEO, on the earnings call

Forward Guidance & Outlook

Alignment Healthcare raised the midpoint of its full-year 2025 guidance across all key metrics. For Q2 2025, the company expects health plan membership of 220,000–222,000, revenue of $950–$965 million, adjusted gross profit of $105–$113 million, and adjusted EBITDA of $10–$18 million. For full-year 2025, guidance calls for year-end membership of 228,000–233,000, revenue of $3,770–$3,815 million, adjusted gross profit of $420–$445 million, and adjusted EBITDA of $38–$60 million. The raised outlook is supported by strong first-quarter clinical performance and enrollment growth momentum.

ALHC YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$300.0M$600.0M$900.0M$628.6M$926.9MRevenue$-2,885,809$-5,393,000Operating Income$-5,199,844$-9,354,000Net Income
$0$300.0M$600.0M$900.0MRevenueOperating IncomeNet Income

ALHC Revenue by Segment

Earned Premiums$918.0M
Other Revenue$8.9M

Figures from SEC filings and company reports. Not investment advice.